New Delhi: Genefitletics, India’s first direct-to-consumer Microbiome Company, launches revolutionary Asia’s first & only Oral microbiome functional activity test-ORAHYG that will unravel the deeper connection between dentistry & systemic health & open up new therapeutic avenues for transformative health outcomes.
ORAHYG sits inside the company’s unique microbiome therapeutics as a service platform (MTAAS) platform- PROTEBA, alongside the company’s gut & vaginal microbiome functional activity tests.
The platform, working at the interaction of system biology & machine learning, has built a human biology model for the oral microbiome. The system uses a biological sample- Saliva, to measure & analyse biochemical reactions at the molecular level at the top of the digestive tube – mouth. It further applies a mathematical model to determine molecular signatures predictive of chronic diseases in order to provide disease-modifying therapeutic interventions.
The molecular insights from this test would give an unprecedented view of the functions of the oral microbiome, their interaction with the gut microbiome & impact on metabolic, cardiovascular, cognitive, skin & auto immune health. Customers would have the option to top this test with a gut microbiome functional activity test to get a transformative view of whole microbial functions & activities & their interaction with a human host.
Sushant Kumar, Founder & CEO of Genefitletics, spelt out, “Mouth is the second largest & second most diverse colonised site for microbiome with 770 species comprising 100 billion microbes residing there. Each place inside the mouth, right from the tongue, throat, saliva & upper surface of the mouth, has a distinctive & unique microbiome ecosystem. Taking care of Oral health goes beyond a sparkling smile & fresh breath. Balancing oral microbiome functions extends its toothprint to overall health & wellbeing. Microbes in the saliva predigest the food an individual eats & convert them into metabolites that not only interact with microbes living in the gut & various other body organs but also influence overall health. Activities & functions of these oral microbes impact blood pressure, cardiovascular health, metabolic health, brain health & more. An imbalanced oral microbiome is said to trigger the onset & progression of type 2 diabetes, arthiritis, heart diseases & even dementia. ORAHYG is a scientific breakthrough & will bring much-needed solutions to bridge the gap between dental health & overall health & longevity. The test is the next step in our revolution to restore human & planetary health.”
